Continuous regional arterial infusion effective for children with acute necrotizing pancreatitis even under
Hiroko Fukushima1, Takashi Fukushima, Ryoko Suzuki
1Department of Pediatrics, University of Tsukuba Hospital, University of Tsukuba, Tsukuba, Japan.
Insights
Severe acute pancreatitis is a critical complication in pediatric cancer patients. Continuous regional arterial infusion of antibiotics and protease inhibitors offers a promising, effective treatment, even during agranulocytosis.
Area of Science:
- Pediatric Oncology
- Gastroenterology
- Critical Care Medicine
Background:
- Severe acute pancreatitis (SAP) is a life-threatening complication in pediatric cancer patients, particularly those undergoing chemotherapy or hematopoietic transplantation.
- Infectious pancreatitis and circulatory collapse are leading causes of mortality in SAP.
- Patients with malignancy and neutropenia are at high risk for fatal SAP.
Observation:
- Three pediatric cancer patients with neutropenia developed severe acute pancreatitis.
- Two patients with severe conditions, including agranulocytosis, were treated with continuous regional arterial infusion (CRAI) of a protease inhibitor and antibiotic.
- One patient received conventional intravenous antibiotic and protease inhibitor therapy with parenteral nutrition.
Findings:
- Continuous regional arterial infusion (CRAI) treatment resulted in earlier symptom resolution compared to conventional therapy, despite more severe initial conditions.
- Both CRAI-treated patients showed successful recovery.
- The patient on conventional therapy also recovered, but with a longer resolution time.
Implications:
- Severe acute pancreatitis is a significant complication in childhood malignancy.
- Continuous regional arterial infusion (CRAI) of protease inhibitors and antibiotics is a well-tolerated and effective treatment for SAP in neutropenic pediatric cancer patients.
- This approach may reduce early mortality associated with pancreatitis in this vulnerable population.
Abstract:
Severe acute pancreatitis is one of the critical conditions that may develop in children with cancer. The leading cause of death due to acute pancreatitis is infectious pancreatitis or circulation collapse. Therefore, patients who develop acute pancreatitis while undergoing chemotherapy or after hematopoietic transplantation are at risk for a life-threatening and fatal course. We treated 140 patients with malignancy from April 2002 to March 2009 at our hospital and encountered 3 patients under neutropenia who developed severe acute pancreatitis. Two of them were successfully treated with continuous regional arterial infusion of a protease inhibitor and antibiotic even under agranulocytosis. Another patient was treated with conventional therapy with intravenous antibiotics plus a protease inhibitor and total or partial parenteral nutrition. Even though the two patients treated with continuous regional arterial infusion presented much more severe conditions, their symptoms resolved earlier. In conclusion, acute pancreatitis is one of the severe complications of childhood malignancy. Even under agranulocytosis, continuous regional arterial infusion of a protease inhibitor and antibiotic was well tolerated and effective among our cases and might reduce early death due to pancreatitis.
Related Concept Videos
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
Acute Pancreatitis II: Clinical Manifestations and Management
Acute Pancreatitis I: Introduction
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury V: Interprofessional Care

